• News

"FDA Says Breast Density Must Be Reported to Women During Mammograms" - Robert Preidt

  • U.S. News & World Report
  • New York, NY
  • (March 27, 2019)

Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed by the U.S. Food and Drug Administration. The FDA would also tighten its regulation of mammogram facilities, giving the agency the power to notify patients if problems are found at a center, so that repeat mammograms can be done at another certified center. "The FDA's proposed amendment is in keeping with the 37 states and District of Columbia, which currently require that patients be informed about breast density," said Laurie Margolies, MD, FACR, director of breast imaging at the Dubin Breast Center at the Icahn School of Medicine at Mount Sinai. “Supplemental screening finds additional cancers in women with negative mammograms. Hopefully, the FDA regulations will mandate payment for supplemental screening so those women who want the extra screening can avail themselves of it."

— Laurie Margolies, MD, FACR, Professor, Radiology, Director, Breast Imaging, The Dubin Breast Center of the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Learn more

Additional coverage: HealthDay;MedPage Today; WebMD;  Healing Well; Clinical Connection;  Doctor's Lounge;  Kaiser Health News; UPI; Modern Healthcare; Medical Xpress